Clinical Trials

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07579286 2026-05-12

LumiNOde

100 enrolled

Breast Neoplasms

NCT02564848 2026-05-11

Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65

200 enrolled

Breast Neoplasms

NCT04333537 2026-05-04

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Phase 2/3 Recruiting

686 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT07508306 2026-04-02

Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity

Recruiting

30 enrolled

Sentinel Lymph Node Biopsy (SLNB)

NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Active not recruiting

518 enrolled

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

NCT03255577 2026-03-05

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

162 enrolled

Breast Neoplasms

NCT06381154 2026-01-30

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04959474 2026-01-23

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

80 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT07343401 2026-01-15

Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development

Completed

40 enrolled

Lymphoid

Lymphoma, Sarcoidosis, Sarcoidosis, Pulmonary

NCT07146295 2026-01-12

INFINITE

1,760 enrolled

Breast Neoplasms, Lymphatic Metastasis

NCT01048853 2026-01-07

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

Phase NA Terminated

137 enrolled 15 charts

Phase 1 Active not recruiting

Cervical Adenocarcinoma

NCT00264602 2025-11-10

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

57 enrolled

Thoracic

Lung Neoplasms

NCT01841749 2025-09-12

CINNAMOME

Completed

228 enrolled 4 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT07121595 2025-08-13

Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

Phase 2 Recruiting

50 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

798 enrolled

Phase NA Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07098507 2025-08-01

RIDES

620 enrolled

Breast Neoplasms

NCT00832429 2025-07-04

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

Phase 2 Completed

20 enrolled 6 charts

Eyelid Sebaceous Gland Carcinoma

NCT03719547 2025-07-01

RACC

800 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT01208974 2025-06-26

Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction

21 enrolled 8 charts

Phase NA Enrolling by invitation

Breast Neoplasms, Carcinoma, Ductal

NCT07023601 2025-06-17

VULCA-NODE

100 enrolled